Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses
NCT ID: NCT06469242
Last Updated: 2025-10-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
106 participants
INTERVENTIONAL
2024-07-18
2024-10-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses
NCT05702541
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses
NCT05338333
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses
NCT06461455
The Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses
NCT05766787
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Toric Contact Lenses
NCT05959200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LID233309, then Oasys MF
Serafilcon A multifocal contact lenses worn in Period 1, followed by senofilcon A multifocal contact lenses worn in Period 2, as randomized. The study lenses will be worn in a daily wear mode in both eyes (bilaterally) during waking hours for at least 10 hours per day. Each wear period is 14 days (-0/+2). CLEAR CARE will be used for daily cleaning and disinfection.
Serafilcon A multifocal contact lenses
Investigational multifocal soft contact lenses
Senofilcon A multifocal contact lenses
Commercially available multifocal soft contact lenses
CLEAR CARE® Cleaning & Disinfecting Solution
Hydrogen peroxide-based contact lens cleaning and disinfection system
Oasys MF, then LID233309
Senofilcon A multifocal contact lenses worn in Period 1, followed by serafilcon A multifocal contact lenses worn in Period 2, as randomized. The study lenses will be worn in a daily wear mode in both eyes (bilaterally) during waking hours for at least 10 hours per day. Each wear period is 14 days (-0/+2). CLEAR CARE will be used for daily cleaning and disinfection.
Serafilcon A multifocal contact lenses
Investigational multifocal soft contact lenses
Senofilcon A multifocal contact lenses
Commercially available multifocal soft contact lenses
CLEAR CARE® Cleaning & Disinfecting Solution
Hydrogen peroxide-based contact lens cleaning and disinfection system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Serafilcon A multifocal contact lenses
Investigational multifocal soft contact lenses
Senofilcon A multifocal contact lenses
Commercially available multifocal soft contact lenses
CLEAR CARE® Cleaning & Disinfecting Solution
Hydrogen peroxide-based contact lens cleaning and disinfection system
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Manifest cylinder equal to or less than 0.75 diopter (D) in each eye.
* Able to wear contact lenses within the available power range with a near ADD of +0.75 D to +2.50 D in each eye.
Exclusion Criteria
* History of amblyopia, strabismus, or binocular vision abnormalities.
* Habitual Oasys MF contact lens wearers or daily disposable contact lens wearers.
* Monovision contact lens wearers and wearers of contact lens in one eye only.
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sr. Clinical Trial Lead, Vision Care
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kurata Eyecare Center
Los Angeles, California, United States
Elsa Pao, OD
Oakland, California, United States
Drs. Giedd, P.A.
Maitland, Florida, United States
Vision Health Institute
Orlando, Florida, United States
Wesley Optometric Consulting
Medina, Minnesota, United States
ProCare Vision Centers, Inc.
Granville, Ohio, United States
Insight Research Clinic LLC
Powell, Ohio, United States
Optometry Group, PLLC
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLM234-C001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.